Newsletter

Int. Rev. Allergol. Clin. Immunol. Family Med., 2015, XXI/2: 073-076 Maximize

Int. Rev. Allergol. Clin. Immunol. Family Med., 2015, XXI/2: 073-076

Title: Knowledge, perception and coverage rates regarding hepatitis b vaccination among patients with a neoplastic disease – results of the pilot study 

Authors: Dawgiałło M, Lech M, Nitsch-Osuch A. 

More details

04-02-2015

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Knowledge, perception and coverage rates regarding hepatitis b vaccination among patients with a neoplastic disease – results of the pilot study


Dawgiałło M1,3, Lech M2, Nitsch-Osuch A3.

1Home Hospicjum, Archdiocese of Warsaw, Poland; 2Academy of Humanities and Economics in Lodz, Poland; 3Department of Family Medicine with the Division of Clinical Internal Medicine and Metabolic, Medical University of Warsaw, Poland

Int. Rev. Allergol. Clin. Immunol. Family Med., 2015; Vol. 21, No. 2, 73

The hepatitis B (hep B) coverage rates in adults in our country are low (30-40%).
The aim of the study
was to determine the knowledge, perception and hepatitis B vaccination coverage rates in patients with a diagnosis of the neoplastic disease. The official data do not provide details regarding coverage rates among risk groups patients.
Material and methods
. The survey was conducted among 110 patients with a diagnosis of the neoplastic diseases, it was validated (kappa score 0,8) and consisted of 28 questions regarding knowledge, perception and coverage rates.
Results
. 64% of respondents declared being vaccinated against hep B, 46% received a full course of vaccination, 16% received two doses of vaccine, 2% received one dose of the vaccine. 50% of respondents found hep B vaccination safe, 35% of respondents found it to be an effective. 55% of patients would recommend hep B vaccination to their family and friends. 56% of respondents believed that patients with a neoplastic diseases should be vaccinated against hep B. The main source of information about vaccinations for patients was a doctor. 37% of responders have never looked for any information regarding vaccinations.
Conclusions
. The hep B vaccination coverage rate among patients with a diagnosis of the neoplastic disease is insufficient. It would be beneficial to increase hep B vaccination rates among a general adult population.

Key words: vaccination, hepatitis B, neoplastic disease